BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1004054 C[C@@H](c1ccc(F)cc1)n1nc(C#N)c2c1nc([nH]c2=O)[C@@H]1CC[C@H]1c1ncccn1 484479 US10934294, Example 1::US11028092, Example 1 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 27.3 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484479&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600345 444854559 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004055 C[C@@H](c1ccc(F)cc1)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1ncccn1 484480 US10934294, Example 2::US11028092, Example 2 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.200 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484480&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600346 444854560 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004056 C[C@H](c1ccc(F)cc1)n1nc(C#N)c2c1nc([nH]c2=O)[C@@H]1CC[C@H]1c1ncccn1 484481 US10934294, Example 3::US11028092, Example 3 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 32.1 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484481&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600347 444854561 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004057 C[C@H](c1ccc(F)cc1)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1ncccn1 484482 US10934294, Example 4::US11028092, Example 4 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 4.80 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484482&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600348 444854562 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004058 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@@H]1CC[C@H]1c1ncccn1 484483 US10934294, Example 5::US11028092, Example 5 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 15.9 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484483&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600349 444854563 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004059 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1ncccn1 484484 US10934294, Example 6::US11028092, Example 6 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.100 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484484&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600350 444854564 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004060 C[C@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@@H]1CC[C@H]1c1ncccn1 484485 US10934294, Example 7::US11028092, Example 7 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 2.80 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484485&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600351 444854565 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004061 C[C@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1ncccn1 484486 US10934294, Example 8::US11028092, Example 8 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 4.70 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484486&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600352 444854566 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004062 FC(F)(F)c1ccc(Cn2nc(C#N)c3c2nc([nH]c3=O)[C@@H]2CC[C@H]2c2ncccn2)cn1 484487 US10934294, Example 9::US11028092, Example 9 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 124 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484487&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600353 444854567 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004063 FC(F)(F)c1ccc(Cn2nc(C#N)c3c2nc([nH]c3=O)[C@H]2CC[C@@H]2c2ncccn2)cn1 484488 US10934294, Example 10::US11028092, Example 10 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 4.80 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484488 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484488&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600354 444854568 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004064 CC(c1ccc(cc1)C#N)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484489 US10934294, Example 11::US10934294, Example 12::US10934294, Example 13::US10934294, Example 14::US11028092, Example 14 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 44.3 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484489&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600355 444854569 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004065 CC(c1ccc(cc1)C#N)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484489 US10934294, Example 11::US10934294, Example 12::US10934294, Example 13::US10934294, Example 14::US11028092, Example 14 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 9.30 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484489&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600355 444854569 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004066 CC(c1ccc(cc1)C#N)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484489 US10934294, Example 11::US10934294, Example 12::US10934294, Example 13::US10934294, Example 14::US11028092, Example 14 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.100 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484489&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600355 444854569 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004067 CC(c1ccc(cc1)C#N)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484489 US10934294, Example 11::US10934294, Example 12::US10934294, Example 13::US10934294, Example 14::US11028092, Example 14 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 1.50 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484489&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600355 444854569 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004068 CC(c1ccc(F)c(F)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484493 US10934294, Example 15::US10934294, Example 16::US10934294, Example 17::US10934294, Example 18::US11028092, Example 18 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 110 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484493&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600356 444854570 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004069 CC(c1ccc(F)c(F)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484493 US10934294, Example 15::US10934294, Example 16::US10934294, Example 17::US10934294, Example 18::US11028092, Example 18 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 3.00 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484493&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600356 444854570 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004070 CC(c1ccc(F)c(F)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484493 US10934294, Example 15::US10934294, Example 16::US10934294, Example 17::US10934294, Example 18::US11028092, Example 18 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.400 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484493&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600356 444854570 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004071 CC(c1ccc(F)c(F)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484493 US10934294, Example 15::US10934294, Example 16::US10934294, Example 17::US10934294, Example 18::US11028092, Example 18 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 11.3 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484493&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600356 444854570 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004072 CC(c1ccc(cc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484497 US10934294, Example 19::US10934294, Example 20::US10934294, Example 21::US10934294, Example 22::US11028092, Example 22 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 12.1 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484497&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600357 444854571 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004073 CC(c1ccc(cc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484497 US10934294, Example 19::US10934294, Example 20::US10934294, Example 21::US10934294, Example 22::US11028092, Example 22 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.010 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484497&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600357 444854571 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004074 CC(c1ccc(cc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484497 US10934294, Example 19::US10934294, Example 20::US10934294, Example 21::US10934294, Example 22::US11028092, Example 22 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 4.50 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484497&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600357 444854571 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004075 CC(c1ccc(cc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484497 US10934294, Example 19::US10934294, Example 20::US10934294, Example 21::US10934294, Example 22::US11028092, Example 22 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 1.80 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484497&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600357 444854571 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004076 CC(c1cccc(c1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484501 US10934294, Example 23::US10934294, Example 24::US10934294, Example 25::US10934294, Example 26::US11028092, Example 26 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 25.0 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484501&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600358 444854572 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004077 CC(c1cccc(c1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484501 US10934294, Example 23::US10934294, Example 24::US10934294, Example 25::US10934294, Example 26::US11028092, Example 26 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 1.80 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484501&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600358 444854572 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004078 CC(c1cccc(c1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484501 US10934294, Example 23::US10934294, Example 24::US10934294, Example 25::US10934294, Example 26::US11028092, Example 26 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 31.9 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484501&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600358 444854572 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004079 CC(c1cccc(c1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484501 US10934294, Example 23::US10934294, Example 24::US10934294, Example 25::US10934294, Example 26::US11028092, Example 26 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.100 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484501&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600358 444854572 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004080 CC(c1cnc(cn1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484505 US10934294, Example 27::US10934294, Example 28::US10934294, Example 29::US10934294, Example 30::US11028092, Example 30 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 19.6 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484505&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600359 444854573 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004081 CC(c1cnc(cn1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484505 US10934294, Example 27::US10934294, Example 28::US10934294, Example 29::US10934294, Example 30::US11028092, Example 30 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.500 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484505&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600359 444854573 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004082 CC(c1cnc(cn1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484505 US10934294, Example 27::US10934294, Example 28::US10934294, Example 29::US10934294, Example 30::US11028092, Example 30 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 272 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484505&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600359 444854573 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004083 CC(c1cnc(cn1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484505 US10934294, Example 27::US10934294, Example 28::US10934294, Example 29::US10934294, Example 30::US11028092, Example 30 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 2.30 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484505&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600359 444854573 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004084 CC(c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(C)cn1 484509 US10934294, Example 31::US10934294, Example 32::US10934294, Example 33::US11028092, Example 33 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 2.20 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484509&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600360 444854574 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004085 CC(c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(C)cn1 484509 US10934294, Example 31::US10934294, Example 32::US10934294, Example 33::US11028092, Example 33 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 154 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484509&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600360 444854574 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004086 CC(c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(C)cn1 484509 US10934294, Example 31::US10934294, Example 32::US10934294, Example 33::US11028092, Example 33 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.040 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484509&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600360 444854574 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004087 CC(c1cnc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484513 US10934294, Example 34::US10934294, Example 35::US10934294, Example 36::US10934294, Example 37::US11028092, Example 37 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 319 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484513&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600362 444854576 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004088 CC(c1cnc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484513 US10934294, Example 34::US10934294, Example 35::US10934294, Example 36::US10934294, Example 37::US11028092, Example 37 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 1.20 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484513&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600362 444854576 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004089 CC(c1cnc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484513 US10934294, Example 34::US10934294, Example 35::US10934294, Example 36::US10934294, Example 37::US11028092, Example 37 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 329 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484513&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600362 444854576 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004090 CC(c1cnc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484513 US10934294, Example 34::US10934294, Example 35::US10934294, Example 36::US10934294, Example 37::US11028092, Example 37 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 50.4 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484513&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600362 444854576 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004091 CC(c1ccc(nc1)C(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484517 US10934294, Example 38::US10934294, Example 39::US10934294, Example 40::US10934294, Example 41::US10934294, Example 42::US10934294, Example 43::US10934294, Example 44::US10934294, Example 45::US11028092, Example 45 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >608 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484517&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600363 444854577 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004092 CC(c1ccc(nc1)C(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484517 US10934294, Example 38::US10934294, Example 39::US10934294, Example 40::US10934294, Example 41::US10934294, Example 42::US10934294, Example 43::US10934294, Example 44::US10934294, Example 45::US11028092, Example 45 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >608 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484517&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600363 444854577 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004093 CC(c1ccc(nc1)C(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484517 US10934294, Example 38::US10934294, Example 39::US10934294, Example 40::US10934294, Example 41::US10934294, Example 42::US10934294, Example 43::US10934294, Example 44::US10934294, Example 45::US11028092, Example 45 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.130 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484517&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600363 444854577 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004094 CC(c1ccc(nc1)C(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484517 US10934294, Example 38::US10934294, Example 39::US10934294, Example 40::US10934294, Example 41::US10934294, Example 42::US10934294, Example 43::US10934294, Example 44::US10934294, Example 45::US11028092, Example 45 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 8.00 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484517&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600363 444854577 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004095 CC(c1ccc(nc1)C(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484517 US10934294, Example 38::US10934294, Example 39::US10934294, Example 40::US10934294, Example 41::US10934294, Example 42::US10934294, Example 43::US10934294, Example 44::US10934294, Example 45::US11028092, Example 45 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >608 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484517&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600363 444854577 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004096 CC(c1ccc(nc1)C(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484517 US10934294, Example 38::US10934294, Example 39::US10934294, Example 40::US10934294, Example 41::US10934294, Example 42::US10934294, Example 43::US10934294, Example 44::US10934294, Example 45::US11028092, Example 45 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 2.00 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484517&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600363 444854577 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004097 CC(c1ccc(nc1)C(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484517 US10934294, Example 38::US10934294, Example 39::US10934294, Example 40::US10934294, Example 41::US10934294, Example 42::US10934294, Example 43::US10934294, Example 44::US10934294, Example 45::US11028092, Example 45 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 82.3 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484517&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600363 444854577 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004098 CC(c1ccc(nc1)C(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484517 US10934294, Example 38::US10934294, Example 39::US10934294, Example 40::US10934294, Example 41::US10934294, Example 42::US10934294, Example 43::US10934294, Example 44::US10934294, Example 45::US11028092, Example 45 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 8.90 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484517&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600363 444854577 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004099 CC(C1CCOCC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484525 US10934294, Example 46::US10934294, Example 47::US10934294, Example 48::US10934294, Example 49::US11028092, Example 49 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 164 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484525&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600364 444854578 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004100 CC(C1CCOCC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484525 US10934294, Example 46::US10934294, Example 47::US10934294, Example 48::US10934294, Example 49::US11028092, Example 49 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.220 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484525&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600364 444854578 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004101 CC(C1CCOCC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484525 US10934294, Example 46::US10934294, Example 47::US10934294, Example 48::US10934294, Example 49::US11028092, Example 49 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.900 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484525&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600364 444854578 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004102 CC(C1CCOCC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484525 US10934294, Example 46::US10934294, Example 47::US10934294, Example 48::US10934294, Example 49::US11028092, Example 49 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 104 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484525&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600364 444854578 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004103 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484529 US10934294, Example 50::US10934294, Example 51::US10934294, Example 52::US10934294, Example 53::US10934294, Example 54::US10934294, Example 55::US10934294, Example 56::US10934294, Example 57::US11028092, Example 57 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >608 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484529&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600365 444854579 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004104 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484529 US10934294, Example 50::US10934294, Example 51::US10934294, Example 52::US10934294, Example 53::US10934294, Example 54::US10934294, Example 55::US10934294, Example 56::US10934294, Example 57::US11028092, Example 57 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >608 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484529&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600365 444854579 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004105 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484529 US10934294, Example 50::US10934294, Example 51::US10934294, Example 52::US10934294, Example 53::US10934294, Example 54::US10934294, Example 55::US10934294, Example 56::US10934294, Example 57::US11028092, Example 57 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 148 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484529&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600365 444854579 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004106 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484529 US10934294, Example 50::US10934294, Example 51::US10934294, Example 52::US10934294, Example 53::US10934294, Example 54::US10934294, Example 55::US10934294, Example 56::US10934294, Example 57::US11028092, Example 57 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.800 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484529&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600365 444854579 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004107 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484529 US10934294, Example 50::US10934294, Example 51::US10934294, Example 52::US10934294, Example 53::US10934294, Example 54::US10934294, Example 55::US10934294, Example 56::US10934294, Example 57::US11028092, Example 57 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >608 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484529&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600365 444854579 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004108 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484529 US10934294, Example 50::US10934294, Example 51::US10934294, Example 52::US10934294, Example 53::US10934294, Example 54::US10934294, Example 55::US10934294, Example 56::US10934294, Example 57::US11028092, Example 57 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 493 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484529&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600365 444854579 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004109 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484529 US10934294, Example 50::US10934294, Example 51::US10934294, Example 52::US10934294, Example 53::US10934294, Example 54::US10934294, Example 55::US10934294, Example 56::US10934294, Example 57::US11028092, Example 57 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 12.6 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484529&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600365 444854579 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004110 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484529 US10934294, Example 50::US10934294, Example 51::US10934294, Example 52::US10934294, Example 53::US10934294, Example 54::US10934294, Example 55::US10934294, Example 56::US10934294, Example 57::US11028092, Example 57 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.010 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484529&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600365 444854579 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004111 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(Br)cn1 484537 US10934294, Example 58::US10934294, Example 59::US11028092, Example 59 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 26.9 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484537 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484537&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600366 444854580 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004112 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(Br)cn1 484537 US10934294, Example 58::US10934294, Example 59::US11028092, Example 59 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.120 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484537 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484537&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600366 444854580 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004113 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(OC(F)F)cn1 484539 US10934294, Example 60::US10934294, Example 61::US11028092, Example 61 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 86.7 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484539&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600367 444854581 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004114 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(OC(F)F)cn1 484539 US10934294, Example 60::US10934294, Example 61::US11028092, Example 61 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.080 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484539&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600367 444854581 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004115 CCc1cnc(nc1)C1CCC1c1nc2n(nc(C#N)c2c(=O)[nH]1)[C@@H](C)c1ccc(nc1)C(F)(F)F 484541 US10934294, Example 62::US11028092, Example 63 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.010 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484541&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600368 444854582 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004116 COc1cnc(nc1)C1CCC1c1nc2n(nc(C#N)c2c(=O)[nH]1)[C@@H](C)c1ccc(nc1)C(F)(F)F 484542 US10934294, Example 63::US10934294, Example 97::US11028092, Example 97 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 5.60 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484542&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600369 444854583 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004117 CC(c1cncc(F)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484543 US10934294, Example 64::US10934294, Example 65::US10934294, Example 66::US10934294, Example 67::US11028092, Example 67 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >67.5 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484543&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600370 444854584 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004118 CC(c1cncc(F)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484543 US10934294, Example 64::US10934294, Example 65::US10934294, Example 66::US10934294, Example 67::US11028092, Example 67 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >67.5 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484543&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600370 444854584 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004119 CC(c1cncc(F)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484543 US10934294, Example 64::US10934294, Example 65::US10934294, Example 66::US10934294, Example 67::US11028092, Example 67 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >67.5 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484543&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600370 444854584 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004120 CC(c1cncc(F)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484543 US10934294, Example 64::US10934294, Example 65::US10934294, Example 66::US10934294, Example 67::US11028092, Example 67 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >67.5 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484543&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600370 444854584 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004121 CC(c1cnn(C)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484547 US10934294, Example 68::US10934294, Example 69::US10934294, Example 70::US10934294, Example 71::US11028092, Example 71 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >67.5 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484547&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 137356894 444854585 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004122 CC(c1cnn(C)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484547 US10934294, Example 68::US10934294, Example 69::US10934294, Example 70::US10934294, Example 71::US11028092, Example 71 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >67.5 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484547&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 137356894 444854585 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004123 CC(c1cnn(C)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484547 US10934294, Example 68::US10934294, Example 69::US10934294, Example 70::US10934294, Example 71::US11028092, Example 71 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >67.5 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484547&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 137356894 444854585 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004124 CC(c1cnn(C)c1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484547 US10934294, Example 68::US10934294, Example 69::US10934294, Example 70::US10934294, Example 71::US11028092, Example 71 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >67.5 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484547&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 137356894 444854585 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004125 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(F)cn1 484551 US10934294, Example 72::US10934294, Example 73::US10934294, Example 74::US10934294, Example 75::US11028092, Example 75 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 54.6 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484551&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600371 444854586 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004126 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(F)cn1 484551 US10934294, Example 72::US10934294, Example 73::US10934294, Example 74::US10934294, Example 75::US11028092, Example 75 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 2.00 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484551&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600371 444854586 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004127 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(F)cn1 484551 US10934294, Example 72::US10934294, Example 73::US10934294, Example 74::US10934294, Example 75::US11028092, Example 75 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 6.20 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484551&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600371 444854586 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004128 CC(c1ccc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(F)cn1 484551 US10934294, Example 72::US10934294, Example 73::US10934294, Example 74::US10934294, Example 75::US11028092, Example 75 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.020 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484551&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600371 444854586 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004129 CC(c1cnc(s1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484555 US10934294, Example 76::US10934294, Example 77::US10934294, Example 78::US10934294, Example 79::US11028092, Example 79 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 354 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484555&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 137356215 444854587 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004130 CC(c1cnc(s1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484555 US10934294, Example 76::US10934294, Example 77::US10934294, Example 78::US10934294, Example 79::US11028092, Example 79 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 153 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484555&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 137356215 444854587 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004131 CC(c1cnc(s1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484555 US10934294, Example 76::US10934294, Example 77::US10934294, Example 78::US10934294, Example 79::US11028092, Example 79 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 1.10 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484555&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 137356215 444854587 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004132 CC(c1cnc(s1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484555 US10934294, Example 76::US10934294, Example 77::US10934294, Example 78::US10934294, Example 79::US11028092, Example 79 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 17.3 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484555&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 137356215 444854587 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004133 CC(c1cnc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1ncc(F)cn1 484559 US10934294, Example 80::US10934294, Example 81::US11028092, Example 81 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.090 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484559&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600372 444854588 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004134 CC(c1cnc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1ncc(F)cn1 484559 US10934294, Example 80::US10934294, Example 81::US11028092, Example 81 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 1.60 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484559&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600372 444854588 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004135 CC(c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(cn1)C#C 484561 US10934294, Example 82::US11028092, Example 82 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.230 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484561&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600373 444854589 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004136 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@@H]1CC[C@H]1c1ncc(F)cn1 484562 US10934294, Example 83::US11028092, Example 83 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 10.8 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484562&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600374 444854590 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004137 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1ncc(F)cn1 484563 US10934294, Example 84::US11028092, Example 84 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.250 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484563&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600375 444854591 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004138 CC(C1CCOCC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(F)cn1 484564 US10934294, Example 85::US10934294, Example 86::US11028092, Example 86 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >607 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484564&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 137357166 444854592 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004139 CC(C1CCOCC1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(F)cn1 484564 US10934294, Example 85::US10934294, Example 86::US11028092, Example 86 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human >607 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484564&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 137357166 444854592 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004140 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1(C)CCC1c1ncccn1 484566 US10934294, Example 87 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 250 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484566&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600376 444854593 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004141 C[C@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1(C)CCC1c1ncccn1 484567 US10934294, Example 88 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.700 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484567&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600377 444854594 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004142 C[C@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@@H]1CC[C@@H]1c1ncc(cn1)C#N InChI=1S/C23H16F3N9O/c1-11(13-2-5-17(29-10-13)23(24,25)26)35-21-18(16(7-28)34-35)22(36)33-20(32-21)15-4-3-14(15)19-30-8-12(6-27)9-31-19/h2,5,8-11,14-15H,3-4H2,1H3,(H,32,33,36)/t11-,14+,15-/m1/s1 LRHPAFNLNDNUCK-BYCMXARLSA-N 484568 US10934294, Example 89 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 140 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484568&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600378 444854595 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004143 C[C@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1ncc(cn1)C#N InChI=1S/C23H16F3N9O/c1-11(13-2-5-17(29-10-13)23(24,25)26)35-21-18(16(7-28)34-35)22(36)33-20(32-21)15-4-3-14(15)19-30-8-12(6-27)9-31-19/h2,5,8-11,14-15H,3-4H2,1H3,(H,32,33,36)/t11-,14+,15+/m1/s1 LRHPAFNLNDNUCK-UGFHNGPFSA-N 484569 US10934294, Example 90 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.300 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484569&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600379 444854596 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004144 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(cn1)C1CC1 484570 US10934294, Example 91::US10934294, Example 92::US11028092, Example 92 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.010 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484570&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600380 444854597 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004145 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(cn1)C1CC1 484570 US10934294, Example 91::US10934294, Example 92::US11028092, Example 92 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 55.7 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484570&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600380 444854597 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004146 C[C@@H](c1cnc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@H]1c1ncccn1 484572 US10934294, Example 93 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.030 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484572&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600381 444854598 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004147 C[C@@H](c1cnc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)[C@@H]1CC[C@H]1c1ncccn1 484573 US10934294, Example 94::US11028092, Example 93 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 1.30 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484573&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600382 444854599 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004148 C[C@@H](c1cnc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1ncccn1 484574 US10934294, Example 95::US11028092, Example 94 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 1.50 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484574&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600383 444854600 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004149 C[C@@H](c1cnc(nc1)C1CC1)n1nc(C#N)c2c1nc([nH]c2=O)[C@@H]1CC[C@@H]1c1ncccn1 484577 US10934294, Example 96 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 37.8 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484577&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600384 444854603 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004150 COc1cnc(nc1)C1CCC1c1nc2n(nc(C#N)c2c(=O)[nH]1)[C@@H](C)c1ccc(nc1)C(F)(F)F 484542 US10934294, Example 63::US10934294, Example 97::US11028092, Example 97 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.150 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484542&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600369 444854583 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004151 C[C@@H](c1ccc(F)cn1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484579 US10934294, Example 100::US10934294, Example 101::US10934294, Example 98::US10934294, Example 99::US11028092, Example 101 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 321 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484579&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600385 444854604 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004152 C[C@@H](c1ccc(F)cn1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484579 US10934294, Example 100::US10934294, Example 101::US10934294, Example 98::US10934294, Example 99::US11028092, Example 101 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 392 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484579&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600385 444854604 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004153 C[C@@H](c1ccc(F)cn1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484579 US10934294, Example 100::US10934294, Example 101::US10934294, Example 98::US10934294, Example 99::US11028092, Example 101 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 1.70 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484579&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600385 444854604 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004154 C[C@@H](c1ccc(F)cn1)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncccn1 484579 US10934294, Example 100::US10934294, Example 101::US10934294, Example 98::US10934294, Example 99::US11028092, Example 101 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 16.0 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484579&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600385 444854604 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004155 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(cn1)C(F)F 484583 US10934294, Example 102::US10934294, Example 103::US10934294, Example 104::US10934294, Example 105::US11028092, Example 105 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 165 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484583&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600386 444854605 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004156 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(cn1)C(F)F 484583 US10934294, Example 102::US10934294, Example 103::US10934294, Example 104::US10934294, Example 105::US11028092, Example 105 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 33.9 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484583&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600386 444854605 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004157 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(cn1)C(F)F 484583 US10934294, Example 102::US10934294, Example 103::US10934294, Example 104::US10934294, Example 105::US11028092, Example 105 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.180 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484583&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600386 444854605 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004158 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(cn1)C(F)F 484583 US10934294, Example 102::US10934294, Example 103::US10934294, Example 104::US10934294, Example 105::US11028092, Example 105 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 21.8 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484583&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600386 444854605 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004159 CC(c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(Cl)cn1 484587 US10934294, Example 106::US10934294, Example 107::US10934294, Example 108::US10934294, Example 109::US11028092, Example 109 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 26.7 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484587&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600387 444854606 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004160 CC(c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(Cl)cn1 484587 US10934294, Example 106::US10934294, Example 107::US10934294, Example 108::US10934294, Example 109::US11028092, Example 109 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 175 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484587&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600387 444854606 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004161 CC(c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(Cl)cn1 484587 US10934294, Example 106::US10934294, Example 107::US10934294, Example 108::US10934294, Example 109::US11028092, Example 109 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.200 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484587&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600387 444854606 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004162 CC(c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1ncc(Cl)cn1 484587 US10934294, Example 106::US10934294, Example 107::US10934294, Example 108::US10934294, Example 109::US11028092, Example 109 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 24.0 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484587&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600387 444854606 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004163 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1nccc(C)n1 InChI=1S/C23H19F3N8O/c1-11-7-8-28-19(30-11)14-4-5-15(14)20-31-21-18(22(35)32-20)16(9-27)33-34(21)12(2)13-3-6-17(29-10-13)23(24,25)26/h3,6-8,10,12,14-15H,4-5H2,1-2H3,(H,31,32,35)/t12-,14-,15-/m0/s1 LNHVCZNICIGKBT-QEJZJMRPSA-N 484591 US10934294, Example 110::US11028092, Example 110 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.050 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484591&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600388 444854607 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004164 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@H]1c1nccc(C)n1 InChI=1S/C23H19F3N8O/c1-11-7-8-28-19(30-11)14-4-5-15(14)20-31-21-18(22(35)32-20)16(9-27)33-34(21)12(2)13-3-6-17(29-10-13)23(24,25)26/h3,6-8,10,12,14-15H,4-5H2,1-2H3,(H,31,32,35)/t12-,14+,15-/m0/s1 LNHVCZNICIGKBT-CFVMTHIKSA-N 484593 US10934294, Example 111 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.040 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484593&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600390 444854609 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004165 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1nccc(n1)C(F)F 484594 BDBM502802::US10934294, Example 112 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.130 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484594&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600391 444854610 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004166 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1nc(cc(n1)C(C)(C)C)C(C)(C)C 484595 US10934294, Example 113::US11028092, Example 113 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.270 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484595&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600392 444854611 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004167 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@H]1CC[C@@H]1c1nccc(n1)C1CC1 484596 US10934294, Example 114::US11028092, Example 114 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 0.040 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484596&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600393 444854612 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004168 C[C@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)[C@@H]1CC[C@H]1c1nccc(n1)C(F)F InChI=1/C23H17F5N8O/c1-10(11-2-5-16(31-9-11)23(26,27)28)36-21-17(15(8-29)35-36)22(37)34-20(33-21)13-4-3-12(13)19-30-7-6-14(32-19)18(24)25/h2,5-7,9-10,12-13,18H,3-4H2,1H3,(H,33,34,37)/t10-,12-,13-/s2 NZDZAQPDDPEGOG-RAIGVLPGSA-N 484597 BDBM502805::US10934294, Example 115 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Homo sapiens 25.3 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484597&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156907384 444854613 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 7F0I,4Y8C,4Y87,4Y86,4QGE,2YY2,4GH6,3K3H,3K3E,2HD1,4G2L,4G2J,4E90,3JSW,3JSI,3DYS,3DYQ,3DYN,3DYL,3DY8,6LZZ,6A3N,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004169 C[C@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CC[C@H]1c1nc(cc(n1)C(F)F)C(F)F InChI=1/C24H17F7N8O/c1-9(10-2-5-16(33-8-10)24(29,30)31)39-22-17(15(7-32)38-39)23(40)37-21(36-22)12-4-3-11(12)20-34-13(18(25)26)6-14(35-20)19(27)28/h2,5-6,8-9,11-12,18-19H,3-4H2,1H3,(H,36,37,40)/t9-,11-,12?/s2 RZWDEVNFBVEYAG-DFWSTUSTSA-N 484598 US10934294, Example 116::US11028092, Example 116 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Homo sapiens 8.30 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484598&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156907385 444854614 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 7F0I,4Y8C,4Y87,4Y86,4QGE,2YY2,4GH6,3K3H,3K3E,2HD1,4G2L,4G2J,4E90,3JSW,3JSI,3DYS,3DYQ,3DYN,3DYL,3DY8,6LZZ,6A3N,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004170 C[C@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CC[C@H]1c1nccc(C)n1 484599 US10934294, Example 117::US11028092, Example 117 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 3.90 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484599&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600394 444854615 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004171 C[C@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CC[C@H]1c1nc(cc(n1)C(C)(C)C)C(C)(C)C 484600 US10934294, Example 118::US11028092, Example 118 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 74.7 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484600&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600395 444854616 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004172 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CC[C@H]1c1nccc(C)n1 484601 US10934294, Example 119 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 36.7 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484601&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600396 444854617 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004173 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CC[C@H]1c1nc(C)cc(C)n1 484602 US10934294, Example 120 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 23.3 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484602&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600397 444854618 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004174 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CCC1c1nccc(n1)C(C)(C)C 484603 US10934294, Example 121::US11028092, Example 121 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 23.7 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484603&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600398 444854619 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004175 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CC[C@H]1c1nc(cc(n1)C(C)(C)C)C(C)(C)C 484604 US10934294, Example 122 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 321 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484604&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600399 444854620 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004176 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CC[C@H]1c1nccc(n1)C(F)F 484605 US10934294, Example 123 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 19.2 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484605&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600400 444854621 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 1004177 C[C@@H](c1ccc(nc1)C(F)(F)F)n1nc(C#N)c2c1nc([nH]c2=O)C1CC[C@H]1c1nccc(n1)C1CC1 484606 US10934294, Example 124 Isoform PDE9A2 of High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (PDE9A2) Human 28.9 US Patent 10.7270/Q2C250JS aid1805307 US10934294 Arasappan, A; Cox, JM; Debenham, JS; Guo, Z; He, J; Hussain, Z; Lai, Z; Li, D; Meng, D; Raghavan, S; Tyagarajan, S 3/2/2021 9/12/2021 Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9598&target=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484606&enzyme=Isoform+PDE9A2+of+High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A+%28PDE9A2%29&column=ki&startPg=0&Increment=50&submit=Search 156600401 444854622 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,4QGE,4Y86,4Y87,4Y8C,6A3N,6LZZ,7F0I,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0